Literature DB >> 2121778

Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.

L J Mandarino1, A Consoli, D E Kelley, J J Reilly, N Nurjhan.   

Abstract

The present studies were undertaken to determine whether fasting hyperglycemia can compensate for decreased insulin-stimulated glucose disposal, oxidation, and storage in noninsulin-dependent diabetes mellitus (NIDDM) as well as to determine whether hyperglycemia normalizes insulin-stimulated skeletal muscle glycogen synthase and pyruvate dehydrogenase (PDH) activities. To accomplish this, we used the glucose clamp technique with isotopic determination of glucose disposal and indirect calorimetry for measuring the pathways of glucose metabolism, and vastus lateralis muscle biopsies to determine the effects of insulin on glycogen synthase and PDH activities. Nine patients with NIDDM and eight matched non-diabetic subjects were infused with insulin (40 mU/m2.min) while plasma glucose was maintained at the prevailing fasting concentration. During insulin infusion, rates of glucose disposal, storage, and oxidation were the same in the two groups. Insulin infusion significantly activated glycogen synthase fractional velocity to the same extent in NIDDM (0.210 +/- 0.056 vs. 0.332 +/- 0.079) and controls (0.192 +/- 0.036 vs. 0.294 +/- 0.050). Insulin infusion increased PDH fractional velocity in controls (from 0.281 +/- 0.022 to 0.404 +/- 0.038), but not in NIDDM (from 0.356 +/- 0.043 to 0.436 +/- 0.060), although the activity of PDH during insulin infusion did not differ between the groups. We conclude that prevailing fasting hyperglycemia normalizes the nonoxidative and oxidative pathways of insulin-stimulated glucose in metabolism in NIDDM and may act as a homeostatic mechanism to normalize muscle glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121778     DOI: 10.1210/jcem-71-6-1544

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.

Authors:  H Vestergaard; C Bjørbaek; T Hansen; F S Larsen; D K Granner; O Pedersen
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

2.  Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Vaag; P Damsbo; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

Review 3.  Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods?

Authors:  L C Groop; E Widén; E Ferrannini
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

Review 4.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

5.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Tissue differences in the response of the pyruvate dehydrogenase complex to a glucose load during the development of obesity in gold-thioglucose-obese mice.

Authors:  J M Bryson; G J Cooney; V R Wensley; J L Phuyal; I D Caterson
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

7.  In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.

Authors:  J F Bak; N Møller; O Schmitz; A Saaek; O Pedersen
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

8.  Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.

Authors:  A A Alzaid; S F Dinneen; D J Turk; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.

Authors:  H Vestergaard; S Lund; F S Larsen; O J Bjerrum; O Pedersen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Low muscle glycogen and elevated plasma free fatty acid modify but do not prevent exercise-induced PDH activation in human skeletal muscle.

Authors:  Kristian Kiilerich; Mikkel Gudmundsson; Jesper B Birk; Carsten Lundby; Sarah Taudorf; Peter Plomgaard; Bengt Saltin; Per A Pedersen; Jorgen F P Wojtaszewski; Henriette Pilegaard
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.